Vaneck Pharmaceutical Etf Probability of Future Etf Price Finishing Under 85.1
| PPH Etf | USD 89.25 0.05 0.06% |
Closest to current price VanEck long CALL Option Payoff at Expiration
VanEck |
VanEck Pharmaceutical Target Price Odds to finish below 85.1
The tendency of VanEck Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 85.10 or more in 90 days |
| 89.25 | 90 days | 85.10 | about 1.85 |
Based on a normal probability distribution, the odds of VanEck Pharmaceutical to drop to $ 85.10 or more in 90 days from now is about 1.85 (This VanEck Pharmaceutical ETF probability density function shows the probability of VanEck Etf to fall within a particular range of prices over 90 days) . Probability of VanEck Pharmaceutical ETF price to stay between $ 85.10 and its current price of $89.25 at the end of the 90-day period is about 76.68 .
Considering the 90-day investment horizon VanEck Pharmaceutical ETF has a beta of -0.11 indicating as returns on the benchmark increase, returns on holding VanEck Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, VanEck Pharmaceutical ETF is likely to outperform the market. Additionally VanEck Pharmaceutical ETF has an alpha of 0.0349, implying that it can generate a 0.0349 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). VanEck Pharmaceutical Price Density |
| Price |
Predictive Modules for VanEck Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as VanEck Pharmaceutical ETF. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VanEck Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VanEck Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. VanEck Pharmaceutical is not an exception. The market had few large corrections towards the VanEck Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold VanEck Pharmaceutical ETF, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of VanEck Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.03 | |
β | Beta against NYSE Composite | -0.11 | |
σ | Overall volatility | 1.45 | |
Ir | Information ratio | -0.08 |
VanEck Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of VanEck Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for VanEck Pharmaceutical ETF can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Latest headline from zacks.com: Should You Invest in the VanEck Pharmaceutical ETF | |
| The fund maintains 99.86% of its assets in stocks |
VanEck Pharmaceutical Technical Analysis
VanEck Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. VanEck Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of VanEck Pharmaceutical ETF. In general, you should focus on analyzing VanEck Etf price patterns and their correlations with different microeconomic environments and drivers.
VanEck Pharmaceutical Predictive Forecast Models
VanEck Pharmaceutical's time-series forecasting models is one of many VanEck Pharmaceutical's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary VanEck Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.
Things to note about VanEck Pharmaceutical ETF
Checking the ongoing alerts about VanEck Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for VanEck Pharmaceutical ETF help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Latest headline from zacks.com: Should You Invest in the VanEck Pharmaceutical ETF | |
| The fund maintains 99.86% of its assets in stocks |
Check out VanEck Pharmaceutical Backtesting, Portfolio Optimization, VanEck Pharmaceutical Correlation, VanEck Pharmaceutical Hype Analysis, VanEck Pharmaceutical Volatility, VanEck Pharmaceutical History as well as VanEck Pharmaceutical Performance. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.